✦ LIBER ✦

Comparison of adverse effects related to pegylated interferon-based therapy for patients with chronic hepatitis B and chronic hepatitis C in Taiwan

✍ Scribed by Jeng-Fu Yang; Yi-Hui Kao; Chia-Yen Dai; Jee-Fu Huang; Ming-Yen Hsieh; Zu-Yau Lin; Shinn-Cherng Chen; Ming-Yuh Hsieh; Liang-Yen Wang; Wan-Long Chuang; Ming-Lung Yu

Book ID: 107593900
Publisher: Springer-Verlag
Year: 2010
Tongue: English
Weight: 280 KB
Volume: 4
Category: Article
ISSN: 1936-0533
DOI: 10.1007/s12072-010-9208-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prevalence and impact of occult hepatiti

Prevalence and impact of occult hepatitis B infection in chronic hepatitis C patients treated with pegylated interferon and ribavirin

✍ Marion Levast; Sylvie Larrat; Marie-Ange Thelu; Sandrine Nicod; Agnès Plages; Al 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 2 views

## Abstract The prevalence of occult hepatitis B, defined by absence of HBsAg and HBV DNA, ranges widely in patients with hepatitis C. This may influence the treatment of hepatitis C and the severity of liver disease. Sensitive and specific real‐time PCR techniques are available commercially and ca

Adverse skin reactions due to pegylated

Adverse skin reactions due to pegylated interferon alpha 2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus

✍ Yuki HASHIMOTO; Hiromi KANTO; Masatoshi ITOH 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 1023 KB

Eicosapentaenoic Acid Supplementation fo

Eicosapentaenoic Acid Supplementation for Chronic Hepatitis C Patients During Combination Therapy of Pegylated Interferon α-2b and Ribavirin

✍ Aiko Kawashima; Ikuyo Tsukamoto; Tomoko Koyabu; Yasuko Murakami; Takayo Kawakami 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 255 KB

Association of genetic polymorphisms wit

Association of genetic polymorphisms with interferon-induced haematologic adverse effects in chronic hepatitis C patients

✍ M. Wada; H. Marusawa; R. Yamada; A. Nasu; Y. Osaki; M. Kudo; M. Nabeshima; Y. Fu 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB

Efficacy of re-treatment with pegylated

Efficacy of re-treatment with pegylated interferon plus ribavirin combination therapy for patients with chronic hepatitis C in Japan

✍ Tsugiko Oze; Naoki Hiramatsu; Takayuki Yakushijin; Kiyoshi Mochizuki; Masahide O 📂 Article 📅 2011 🏛 Springer Japan 🌐 English ⚖ 297 KB

Efficacy and safety of pegylated interfe

Efficacy and safety of pegylated interferon alpha-2a therapy for chronic hepatitis C in HIV-infected patients with haemophilia

✍ R.-F. ZHANG; H.-Q. SUN; Q. HUANG; J.-R. WANG; X.-X. ZHANG; X.-N. LIU; Q. MA; H.- 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB